Precigen PGEN
NASDAQ PGEN
$6.60 -0.23 (-3.37%)
As of: Oct 21, 2026 · 2:10 PM EDT

Precigen (PGEN) Current Leases (2012 - 2013)

Updated

Precigen (PGEN) recorded Current Leases of $30,000 in Q4 2013, down 38.8% from $49,000 a year earlier and down 9.1% from the prior quarter.

Analysis

Precigen (PGEN) Current Leases (2012 - 2013) Analysis & Trends

Starting with Q4 2012, Precigen's Current Leases history includes 4 quarters.

  • Across earlier years, Current Leases came in at $49,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,133.90 Bn 1,102.48 Bn 19.71 Bn -
2 Johnson & Johnson 616.46 Bn 534.99 Bn 17.26 Bn -
3 AbbVie 501.26 Bn 474.37 Bn 12.70 Bn -
4 Merck 367.00 Bn 321.38 Bn 12.21 Bn -
5 Novartis Ag 297.91 Bn 261.90 Bn 11.24 Bn -
6 Astrazeneca 261.33 Bn 235.02 Bn 12.86 Bn -
7 Amgen 235.82 Bn 191.22 Bn 7.24 Bn -
8 Gilead Sciences 190.63 Bn 164.82 Bn 6.22 Bn -
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn -
10 Precigen 2.36 Bn 2.05 Bn 52.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 30,000.00
Sep 30, 2013 33,000.00
Jun 30, 2013 32,000.00
Dec 31, 2012 49,000.00
API Access

Precigen Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=PGEN&period=max&api_key=YOUR_API_KEY